Viewbix refines proposed Quantum X Labs acquisition terms

Viewbix (VBIX) announced the signing of an updated non-binding term sheet with Quantum X Labs and its shareholders, refining the proposed terms previously announced strategic acquisition. Building on the November 5, 2025 announcement, the revised terms reduce Viewbix’s initial equity issuance to 40.0% of its post-closing issued and outstanding capital stock, inclusive of shares issued concurrently via a PIPE financing of $3 million that the Company announced on November 5, 2025, issuable in shares of its common stock and pre-funded warrants, in exchange for 100% of Quantum’s issued and outstanding share capital on a fully diluted basis. In addition, the Company may issue additional shares of its common stock and/or pre-funded warrants, which shall not represent in the aggregate more than 65.0% of the Company’s issued and outstanding capital stock, including the Initial Shares, upon achievement of the following milestones as follows: 6% of the Company’s issued and outstanding capital stock upon the completion of prototype Phase 1 and either a binding collaboration with a recognized quantum hardware provider or filing of a patent within 18 months of closing. An additional 8% of the Company’s issued and outstanding capital stock upon the completion of prototype Phase 2 and either a technical validation report from a recognized design partner confirming successful beta performance or filing of an additional patent within 30 months of closing. An additional 11% of the Company’s issued and outstanding capital stock following beta testing of the platform with partners and/or filing of another additional patent within 36 months of closing.